John Overdeck’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Hold
13,276
﹤0.01% 4865
2026
Q1
$136K Buy
13,276
+2,530
+24% +$16.5K ﹤0.01% 4349
2025
Q4
$81.3K Buy
+10,746
New +$49.2K ﹤0.01% 3877
2024
Q4
Sell
-25,847
Closed -$115K 3202
2024
Q3
$115K Sell
25,847
-4,366
-14% -$102K ﹤0.01% 2884
2024
Q2
$801K Sell
30,213
-12,348
-29% -$291K ﹤0.01% 2108
2024
Q1
$1.17M Buy
42,561
+12,154
+40% +$386K ﹤0.01% 1854
2023
Q4
$739K Buy
30,407
+3,702
+14% +$65.7K ﹤0.01% 2242
2023
Q3
$539K Sell
26,705
-8,964
-25% -$230K ﹤0.01% 2237
2023
Q2
$1.05M Sell
35,669
-6,472
-15% -$184K ﹤0.01% 1919
2023
Q1
$1.05M Buy
42,141
+8,107
+24% +$261K ﹤0.01% 1843
2022
Q4
$1.08M Sell
34,034
-2,030
-6% -$64K ﹤0.01% 1656
2022
Q3
$1.07M Buy
36,064
+8,221
+30% +$284K ﹤0.01% 1432
2022
Q2
$849K Buy
27,843
+21,017
+308% +$1.93M ﹤0.01% 1612
2022
Q1
$921K Sell
6,826
-9,362
-58% -$987K ﹤0.01% 1744
2021
Q4
$2.11M Sell
16,188
-6,132
-27% -$775K ﹤0.01% 1872
2021
Q3
$2.09M Buy
22,320
+14,440
+183% +$1.47M ﹤0.01% 1948
2021
Q2
$807K Buy
+7,880
New +$1.38M ﹤0.01% 2669

Other funds holding LONA

John Overdeck's LONA Position: Q2 2026 in Review

John Overdeck held its LeonaBio Inc (LONA) position steady in Q2 2026 at 13,276 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

John Overdeck first reported a position in LONA in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.11M in Q4 2021. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • John Overdeck held 13,276 shares of LeonaBio Inc worth $122K as of Q2 2026.
  • John Overdeck left its LeonaBio Inc share count unchanged in Q2 2026.
  • LeonaBio Inc made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4865 holding.
  • John Overdeck first reported a position in LeonaBio Inc in Q2 2021 and has held it in 17 quarters since.
  • John Overdeck's LeonaBio Inc position peaked at $2.11M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.